Intuitive Surgical, Inc. Share Price

Equities

ISRG

US46120E6023

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 21:00:00 14/05/2024 BST Pre-market 12:00:34
384.2 USD +0.87% Intraday chart for Intuitive Surgical, Inc. 380.2 -1.03%
Sales 2024 * 8.03B 637B Sales 2025 * 9.31B 738B Capitalization 136B 10,806B
Net income 2024 * 1.97B 156B Net income 2025 * 2.27B 180B EV / Sales 2024 * 16.3 x
Net cash position 2024 * 5.19B 412B Net cash position 2025 * 7.75B 615B EV / Sales 2025 * 13.8 x
P/E ratio 2024 *
69.4 x
P/E ratio 2025 *
60.6 x
Employees 13,676
Yield 2024 *
-
Yield 2025 *
-
Free-Float 99.45%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.03%
1 week-1.15%
Current month+3.66%
1 month-0.16%
3 months+0.64%
6 months+31.74%
Current year+13.88%
More quotes
1 week
379.67
Extreme 379.67
389.76
1 month
364.17
Extreme 364.17
389.78
Current year
320.26
Extreme 320.26
403.76
1 year
254.85
Extreme 254.85
403.76
3 years
180.07
Extreme 180.07
403.76
5 years
120.17
Extreme 120.1667
403.76
10 years
40.27
Extreme 40.27
403.76
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 31/03/96
President 56 29/02/96
Director of Finance/CFO 52 31/03/13
Members of the board TitleAgeSince
Director/Board Member 65 31/03/17
Director/Board Member 66 18/10/07
Director/Board Member 71 31/03/10
More insiders
Date Price Change Volume
14/05/24 384.2 +0.87% 913,529
13/05/24 380.9 -1.51% 1,070,927
10/05/24 386.7 +0.32% 853,114
09/05/24 385.4 +1.34% 882,194
08/05/24 380.4 -2.13% 1,107,975

Delayed Quote Nasdaq, May 14, 2024 at 09:00 pm

More quotes
Intuitive Surgical, Inc. specializes in the design, manufacturing, and marketing of robotic surgical assistance video systems. The systems consist of a surgical console, arm, remote-controlled endoscope, and 3D visual immersion system. Net sales break down by activity as follows: - sale of instruments and accessories (60%): primarily wrist cuffs; - sale of robotic systems (23.6%): systems marketed under the da Vinci brand (1,370 units sold in 2023) and intended primarily for urological, cardio-thoracic, and gynecological surgeries; - installation and training services (16.4%). The United States accounts for 65.8% of net sales.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
384.2 USD
Average target price
420.4 USD
Spread / Average Target
+9.42%
Consensus